LEAA
- Company typePrivate
- Founded2021
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
LEAA firmographics
Firmographics- Name
- LEAA
- Legal name
- LEAA (US), INC.
- Website
- https://leaa.io
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
LEAA industry classification
Industry- Product category
- Home Healthcare Services
- NAICS
- Home Health Care Services (621610), Medical and Diagnostic Laboratories (6215), Ambulatory Health Care Services (621)
- SIC
- Services-Home Health Care Services (8082), Services-Medical Laboratories (8071), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Hospital-at-Home / Acute Care at Home Programs (HLAFAEAH)
- akta.pro secondary industries
- Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Home Infusion Therapy & IV Nursing Services (HLADAFAG)
Keywords
Where LEAA is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
LEAA business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales
LEAA product offering
Product offeringCore offering
LEAA delivers medical house call services directly to patients' homes, providing on-site infectious disease testing (COVID-19 BA.5, Omicron, Monkeypox), monoclonal antibody infusion therapies (Evusheld, Bebtelovimab), portable X-ray imaging, and blood work. The service is targeted at individuals who need diagnostic or therapeutic care without visiting a clinical facility, particularly during infectious disease outbreaks.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical House Call Services Core at-home medical visit service bringing healthcare personnel to a patient's residence to administer diagnostics, lab work, and treatments that would otherwise require a clinic or hospital visit. Targeted at individuals seeking convenient, in-home care.
- COVID-19 Testing (BA.5 / Omicron) At-home COVID-19 testing service covering BA.5 and Omicron variants, administered by mobile medical personnel for patients who cannot or prefer not to visit clinical testing sites.
- Monkeypox Testing At-home Monkeypox testing administered by visiting healthcare staff, providing private diagnostic access for patients concerned about exposure in clinical settings.
- Evusheld (COVID-19 Monoclonal Antibody Therapy) Home administration of Evusheld, a monoclonal antibody therapy for COVID-19 pre-exposure prophylaxis, targeted at immunocompromised patients.
- Bebtelovimab (COVID-19 Monoclonal Antibody Treatment) Home administration of Bebtelovimab monoclonal antibody treatment for active COVID-19 infection, delivered to patients at their residence.
- In-Home X-Ray Imaging Portable X-ray imaging brought directly to the patient's home, enabling diagnostic imaging without the need to visit a radiology clinic or hospital.
- In-Home Blood Work Mobile phlebotomy and laboratory blood draw services performed at the patient's residence, with samples sent for laboratory analysis.
Companies that use LEAA
Customer profileIdeal customer profiles1 record
LEAA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
LEAA partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights2 records
LEAA competitors and assessment
Company assessmentDirect peers
- DispatchHealth: DispatchHealth is the leading US mobile acute-care provider, sending clinicians and medics to patient homes for diagnoses, treatments, and procedures. Directly comparable to LEAA's medical house-call model across in-home diagnostics, lab work, and acute interventions.
- Heal: Heal is a tech-enabled doctor house-call service operating in major US metros, providing primary care, urgent care, and lab services in the home. Closely mirrors LEAA's at-home physician visit, lab draw, and diagnostic offering.
- Pivotal Health: Pivotal Health provides mobile urgent care and primary care delivered to patient homes, including labs, diagnostics, and treatments. Comparable to LEAA in the in-home acute and diagnostic care category.
- Landmark Health: Landmark Health delivers home-based medical care to complex, chronic, and frail elderly patients using mobile provider teams. Operates in the same in-home clinical care space as LEAA with overlapping services like lab draws and in-home assessments.
- Sollis Health: Sollis Health runs a membership-based concierge medical practice with house calls, in-home lab draws, and imaging services. Closely aligned with LEAA's concierge-style house-call offering and lab/X-ray at home positioning.
- ConciergeMD: ConciergeMD offers private doctor house calls, mobile lab draws, IV therapy, and in-home COVID testing. Closely matches LEAA's combination of house-call physician services, in-home lab work, and pandemic-era treatments like monoclonal antibodies.
Regional players
- House Call Doctor Los Angeles: A regional concierge house-call practice serving the Los Angeles market with in-home labs, IV therapy, and acute care. Comparable service mix to LEAA, but geographically limited and not a national competitor.
Broad incumbents
- Amedisys: Amedisys is one of the largest US home health and hospice operators, providing skilled nursing, therapy, and home-based care across the country. Broad incumbent overlap with LEAA's in-home skilled services, though Amedisys operates at massive scale across a much wider portfolio.
- ChenMed: ChenMed operates value-based primary care clinics focused on seniors, with significant in-home and house-call components delivered alongside its clinic footprint. Overlaps with LEAA on at-home primary and diagnostic care but at much greater scale and with a clinic-anchored model.
Emerging players
- AccuReference Medical Lab: AccuReference provides mobile phlebotomy and in-home specimen collection services across multiple states, supplying labs and at-home clinicians. Comparable to LEAA's blood work / lab draw component, but as a specialized specimen-collection provider rather than full house-call operator.
Market position
Strengths3 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights4 records
Customer concentration
LEAA social profiles
Digital presenceLEAA financial estimates
Financial estimateRevenue estimate
Valuation estimate
LEAA leadership team
Management profileNumber of profiles
Profiles1 record
LEAA funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LEAA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LEAA
What does LEAA do?
LEAA delivers medical house call services directly to patients' homes, providing on-site infectious disease testing (COVID-19 BA.5, Omicron, Monkeypox), monoclonal antibody infusion therapies (Evusheld, Bebtelovimab), portable X-ray imaging, and blood work. The service is targeted at individuals who need diagnostic or therapeutic care without visiting a clinical facility, particularly during infectious disease outbreaks.
Is LEAA a public or private company?
LEAA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was LEAA founded?
LEAA was founded in 2021. It employs 1 to 10 people.
Where is LEAA based?
LEAA is headquartered in New York, United States, in the North America region.
Who are LEAA's main competitors?
Direct peers on record are DispatchHealth, Heal, Pivotal Health, Landmark Health, Sollis Health and ConciergeMD. House Call Doctor Los Angeles is listed as a regional player. Broad incumbents are Amedisys and ChenMed. AccuReference Medical Lab is listed as an emerging player.
Does LEAA have an API?
No public API is recorded for LEAA.
What industry is LEAA in?
LEAA's product category is Home Healthcare Services. Its primary akta.pro industry code is HLAFAEAH, Hospital-at-Home / Acute Care at Home Programs, with a secondary code of HSABACAN, Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home). Its NAICS code is 621610 and its SIC code is 8082.